Literature DB >> 33570865

Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.

Simona Stolnicu, Kay J Park, Takako Kiyokawa, Esther Oliva, W Glenn McCluggage, Robert A Soslow.   

Abstract

The incidence of endocervical adenocarcinoma, the second most common cervical cancer in the world, has been on the rise. While most cervical cancers are squamous cell carcinomas and associated with high-risk oncogenic human papillomavirus (HPV), approximately 15% of endocervical adenocarcinomas, which now represent about one quarter of all cervical cancers, are HPV-independent. In this review, we will focus on the shortcomings of historical histologic classification systems of female genital tract tumors as they pertain to endocervical adenocarcinomas, and we will highlight the advantages of the new International Endocervical Adenocarcinoma Criteria and Classification system, which forms the basis for the WHO 2020 classification. We will cover the various histologic types, subtypes, and variants of endocervical adenocarcinoma with regard to morphology, immunophenotype, molecular genetics, HPV status and differential diagnosis, and we will provide International Society of Gynecological Pathologists recommendations for diagnosing these tumors.
Copyright © 2021 International Society of Gynecological Pathologists. Published by Wolters Kluwer Health, Inc. on behalf of the International Society of Gynecological Pathologists.

Entities:  

Mesh:

Year:  2021        PMID: 33570865      PMCID: PMC7888380          DOI: 10.1097/PGP.0000000000000751

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   3.326


  64 in total

1.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances.

Authors:  Edyta C Pirog; Kay J Park; Takako Kiyokawa; Xun Zhang; Wen Chen; David Jenkins; Wim Quint
Journal:  Adv Anat Pathol       Date:  2019-01       Impact factor: 3.875

Review 3.  Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Authors:  Kosei Hasegawa; Shoji Nagao; Masanori Yasuda; David Millan; Akila N Viswanathan; Rosalind M Glasspool; Mojgan Devouassoux-Shisheboran; Alan Covens; Domenica Lorusso; Christian Kurzeder; Jae-Weon Kim; Laurence Gladieff; Jane Bryce; Michael Friedlander; Keiichi Fujiwara
Journal:  Int J Gynecol Cancer       Date:  2014-11       Impact factor: 3.437

4.  Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.

Authors:  Abha Goyal; Bin Yang
Journal:  Int J Gynecol Pathol       Date:  2014-11       Impact factor: 2.762

5.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.

Authors:  H O Smith; M F Tiffany; C R Qualls; C R Key
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

6.  Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases.

Authors:  R H Young; R E Scully
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

7.  Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas.

Authors:  Karen L Talia; Richard Wing-Cheuk Wong; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2019-05       Impact factor: 2.762

8.  PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.

Authors:  Joseph T Rabban; Stephanie McAlhany; Melinda F Lerwill; James P Grenert; Charles J Zaloudek
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

Review 9.  The Evolving Spectrum of Precursor Lesions of Cervical Adenocarcinomas.

Authors:  Simona Stolnicu; Karen L Talia; W Glenn McCluggage
Journal:  Adv Anat Pathol       Date:  2020-09       Impact factor: 3.875

10.  Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Cervix: A Study on Morphologic Diversity.

Authors:  Simona Stolnicu; Sheila Segura; Carlos Parra-Herran; Lars-Christian Horn; Lynn Hoang; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kyokawa; Isabel Alvarado-Cabrero; Esther Oliva; Robert A Soslow; Kay J Park
Journal:  Am J Surg Pathol       Date:  2020-07       Impact factor: 6.298

View more
  4 in total

Review 1.  Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer.

Authors:  Siaw Shi Boon; Ho Yin Luk; Chuanyun Xiao; Zigui Chen; Paul Kay Sheung Chan
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 2.  Progress in the pathological arena of gynecological cancers.

Authors:  W Glenn McCluggage
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

Review 3.  Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists.

Authors:  Karen L Talia; Esther Oliva; Joseph T Rabban; Naveena Singh; Simona Stolnicu; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

4.  New Insights in the Diagnosis of Rare Adenocarcinoma Variants of the Cervix-Case Report and Review of Literature.

Authors:  Cristina Secosan; Oana Balint; Aurora Ilian; Lavinia Balan; Ligia Balulescu; Andrei Motoc; Delia Zahoi; Dorin Grigoras; Laurentiu Pirtea
Journal:  Healthcare (Basel)       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.